Price Chart

Profile

Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients’ lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.
URL https://www.kinetabio.com
Investor Relations URL https://kinetabio.com/investors/
HQ State/Province Washington
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Feb. 29, 2024 (est.)
Last Earnings Release Nov. 03, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients’ lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.
URL https://www.kinetabio.com
Investor Relations URL https://kinetabio.com/investors/
HQ State/Province Washington
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Feb. 29, 2024 (est.)
Last Earnings Release Nov. 03, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A